Baseline NT-proBNP levels in Black and White patients with wild-type ATTR-CM reflect disease severity rather than inherent ...
Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study March 23, 2026 4:30 ...
Inger Andersen, UNEP Executive Director, urges leaders to safeguard environmental security by backing science, multilateral ...
Background Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately ...
Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; ...
Cost-related delayed or forgone care was associated with 78% higher odds of an ED visit among Latino adults, indicating ...
Dr. Galinos Barmparas shares expert insights on how frailty shapes operative risk and the subsequent clinical trajectory ...
Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), joins the global ...
Study of 2 million people shows genetic risk for nine major mental illnesses including schizophrenia and anxiety, varies by age and treatment, often lacking specificity.
Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate AS ...
The symptoms are usually seen between 18 and 36 months of age, although there is a wide range of presentation, which is often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results